Oculus Innovative Sciences to Collaborate with Onset Therapeutics
Their initial collaboration will target atopic dermatitis and related conditions.
Their initial collaboration will target atopic dermatitis and related conditions.
Petaluma, Calif.-based Oculus Innovative Sciences specializes in the development of products to treat and prevent infections in wounds.
Hoji Alimi, Founder and CEO of Oculus Innovative Sciences, discusses his company with William Dawson of LifeTech Capital at the 2010 OneMedForum in San Francisco.
Copyright © 2024 | WordPress Theme by MH Themes